DOI: https://dx.doi.org/10.18565/therapy.2024.4.59-64
Tatarintseva Z.G., Kosmachova E.D.
1) Research Institute – Regional Clinical Hospital No. 1 named after professor S.V. Ochapovsky, Krasnodar 2) Kuban State Medical University of the Ministry of Healthcare of Russia, Krasnodar
1. Filardo G., Damiano R.J. Jr., Ailawadi G. et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 2018; 104(12): 985–92. https://doi.org/10.1136/heartjnl-2017-312150. PMID: 29326112. 2. Harrison S., Lane D., Banach M., Mastej M. et al.; LIPIDOGRAM2015 Investigators. Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study. Atherosclerosis. 2020; 312: 16–22. https://doi.org/10.1016/j.atherosclerosis.2020.08.026. PMID: 32947222. 3. Zhang R., Fan Y., Xue Y. et al. The LDL/HDL ratio predicts long-term risk of coronary revascularization in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: A cohort study. Brazil J Med Biol Res. 2022; 55: e11850. https://doi.org/10.1590/1414-431x2021e11850. PMID: 35137855. PMCID: PMC8852154. 4. Zhu Y.Y., Hayward P.A., Hare D.L. et al. Effect of lipid exposure on graft patency and clinical outcomes: Arteries and veins are different. Eur J Cardiothorac Surg. 2014; 45(2): 323–28. https://doi.org/10.1093/ejcts/ezt261. PMID: 23671205. 5. Allan V., Honarbakhsh S., Casas J.P. et al. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thromb Haemost. 2017; 117(5): 837–50. https://doi.org/10.1160/TH16-11-0825. PMID: 28229164. PMCID: PMC5442605. 6. Dieberg G., Smart N.A., King N. On-vs. off-pump coronary artery bypass grafting: A systematic review and meta-analysis. Int J Cardiol. 2016; 223: 201–11. https://doi.org/10.1016/j.ijcard.2016.08.250. PMID: 27541655. 7. Zhao D., Edelman J., Seco M. et al. Coronary artery bypass grafting with and without manipulation of the ascending aorta: A network meta-analysis. J Am Coll Cardiol. 2017; 69(8): 924–36. https://doi.org/10.1016/j.jacc.2016.11.071. PMID: 21511187. 8. El-Chami M.F., Kilgo P.D., Elfstrom K.M. et al. Prediction of new onset atrial fibrillation after cardiac revascularization surgery. Am J Cardiol. 2012; 110(5): 649–54. https://doi.org/10.1016/j.amjcard.2012.04.048. PMID: 22621801. 9. Turkkolu S.T., Selcuk E., Koksal C. Biochemical predictors of postoperative atrial fibrillation following cardiac surgery. BMC Cardiovasc Disord. 2021; 21(1): 167. https://doi.org/10.1186/s12872-021-01981-z. PMID: 33836659. PMCID: PMC8033715. 10. Aydin M., Susam I., Kilicaslan B. et al. Serum cholesterol levels and postoperative atrial fibrillation. J Cardiothorac Surg. 2014; 9: 69. https://doi.org/10.1186/1749-8090-9-69. PMID: 24712763. PMCID: PMC4234996. 11. Trieb M., Kornej J., Knuplez E. et al. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. Basic Res Cardiol. 2019; 114(4): 27. https://doi.org/10.1007/s00395-019-0735-0. PMID: 31069509. 12. Okin P.M., Hille D.A., Wachtell K. et al. On-treatment HDL cholesterol predicts incident atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Blood Press. 2020; 29(5): 319–26. https://doi.org/10.1080/08037051.2020.1782171. PMID: 32586143. 13. Yao Y., Liu F., Wang Y., Liu Z. Lipid levels and risk of new-onset atrial fibrillation: A systematic review and dose-response meta-analysis. Clin Cardiol. 2020; 43(9): 935–43. https://doi.org/10.1002/clc.23430. PMID: 32720403. PMCID: PMC7462197. 14. Yu M.H., Zhang R.J., Yu X.Y. et al. Association of LDL to HDL ratio with new-onset atrial fibrillation after on-pump coronary artery bypass graft surgery. BMC Cardiovasc Disord. 2022; 22(1): 564. https://doi.org/10.1186/s12872-022-03016-7. PMID: 36564701. PMCID: PMC9783402.
Zoya G. Tatarintseva, MD, PhD (Medicine), head of the department of Research Institute – Regional Clinical Hospital No. 1 named after professor S.V. Ochapovsky. Address: 350086, Krasnodar, 167 1st May St.
E-mail: z.tatarintseva@list.ru
ORCID: https://orcid.org/0000-0002-3868-8061
Elena D. Kosmachova, MD, Dr. Sci. (Medicine), professor, head of the Department of therapy No. 1 of the faculty of advanced training and professional retraining of specialists, Kuban State Medical University of the Ministry of Healthcare of Russia, chief medical officer of Research Institute – Regional Clinical Hospital No. 1 named after professor S.V. Ochapovsky. Address: 350063, Krasnodar, 4 Mitrofana Sedina St.
E-mail: kosmachova_h@mail.ru
ORCID: https://orcid.org/0000-0001-5690-2482